Clinical Trials Browser

Phase 2 × Lymphoma × galiximab × Clear all

NCT00117975 2016-07-06

Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Follicular

NCT00516217 2016-07-06

Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase 2 Completed

30 enrolled 9 charts

Hodgkin Disease, Lymphoma